Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
Background. Inhaled hypertonic saline solutions (IHSS) are included in the list of mandatory prescriptions in the treatment of cystic fibrosis (CF). However, some patients with CF may develop bronchial hyperreactivity (BHR), which may be the cause of violation of the treatment protocol. The purpose...
Saved in:
Main Authors: | S.I. Ilchenko (Author), A.O. Fialkovska (Author), K.V. Skriabinа (Author), S.G. Ivanus (Author) |
---|---|
Format: | Book |
Published: |
Zaslavsky O.Yu.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis
by: K.V. Skriabinа, et al.
Published: (2023) -
Analysis of the structure and antibiotic resistance of etiologically significant pathogens of chronic lower respiratory tract infection in children with cystic fibrosis living in Dnipro
by: S.I. Ilchenko, et al.
Published: (2020) -
Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
by: Vito Terlizzi, et al.
Published: (2021) -
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
by: Jefferson Antonio Buendía, et al.
Published: (2020) -
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial
by: Raffaella Nenna, et al.
Published: (2017)